IVABRADIN TEVA
5MG TBL FLM 56 KAL
Announcement of launch, break or close-out of marketing of a medicinal product
| Type of announcement | Effective date | Alternate medicines ? | Reason for interruption/cessation of marketing | Estimated renewal date |
|---|---|---|---|---|
| Interruption of marketing | 01.04.2022 |
0133072, 0133078, 0133252, 0219093, 0253755, 0025969, 0025973 |
Capacity/distribution reasons | 01.12.2022 |
| Resumption of marketing | 19.08.2021 | |||
| Interruption of marketing | 05.04.2021 |
0132486, 0133072, 0133078, 0133252, 0025969, 0025973 |
Manufacturing reasons | 15.05.2021 |
| Resumption of marketing | 12.11.2020 | |||
| Interruption of marketing | 14.08.2020 |
0132486, 0133072, 0133078, 0133252, 0219093, 0025969, 0025973 |
Manufacturing reasons | 30.09.2020 |
| Placing on the market | 01.09.2017 |
All reports are available in the Overview.
cz